Aurinia Pharmaceuticals Inc (AUPH) News

Latest headlines that mention AUPH, newest first · each headline opens the original publisher

AUPH quote

Last price: $17.07
Day change: +1.01%
Next earnings: 2026-11-03

Quote & chart Expected move Insider trading IV rank history

AUPH headlines

latest coverage

Investing.com 1d ago

TD Cowen raises Aurinia Pharmaceuticals price target on cost outlook

General T3AUPH

Seeking Alpha News 1mo ago

Aurinia: Lupkynis Is A Cash Cow, But Competition And Patent Risks Cap The Upside

General T2AUPH

Yahoo Finance 1mo ago

Aurinia’s (AUPH) Profits Surge While Its One Drug Just Got Company

General T2AUPH

Yahoo Finance 1mo ago

Could Aurinia Pharmaceuticals (AUPH) Stock Win Big After its LUPKYNIS Patent Settlement With Teva Pharmaceuticals (TEVA)?

General T2AUPH TEVA

Seeking Alpha 2mo ago

Aurinia settles Lupkynis patent litigation with Teva

General T2AUPH TEVA

Seeking Alpha News 2mo ago

Aurinia Pharmaceuticals Doubles Down On Its Pipeline

General T2AUPH

Yahoo Finance 3mo ago

Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?

General T2AUPH

Yahoo Finance 4mo ago

Aurinia Pharmaceuticals and Four More Stocks See Activist Action

General T2AUPH

Motley Fool 4mo ago

Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million

This biopharma firm, focused on therapies for autoimmune diseases, reported a recent insider buy amid a year of strong share performance.

General T3AUPH

Investing.com 4mo ago

Form 13D/A Aurinia Pharmaceuticals Inc. For: 4 June

General T3AUPH

Seeking Alpha News 4mo ago

Aurinia: Cash-Generating Today, Pipeline-Driven Tomorrow

General T2AUPH

Seeking Alpha News 4mo ago

Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript

General T2AUPH

Seeking Alpha 4mo ago

Tang Capital takes 10% stake in Aurinia Pharma

General T2AUPH

Investing.com 4mo ago

Form 144 AURINIA PHARMACEUTICALS INC. For: 2 June

General T3AUPH

Investing.com 5mo ago

Kezar Life Sciences acquired by Aurinia Pharma U.S.; Nasdaq delisting follows

M&A T3AUPH KZR

Seeking Alpha 5mo ago

Aurinia Pharma GAAP EPS of $0.25 beats by $0.05, revenue of $77.7M beats by $0.72M

Earnings T2AUPH

AUPH news alerts

Get an alert by email or push when a new headline mentions AUPH.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.